Rodan & Fields, LLC (Rodan + Fields), a prestige, dermatology-inspired skincare brand, and the #1 skincare brand in North America has announced the launch of SPOTLESS, a patent-pending teen and young adult acne solution. Stanford-trained dermatologists Dr. Katie Rodan and Dr. Kathy Fields, who transformed at-home solutions for millions with their first acne success, are leveraging their 25-plus years of experience to revolutionize the category once again. With SPOTLESS, Rodan + Fields offers a solution to treat acne, a debilitating dermatological condition and the #1 skin condition in the US, which impacts 85 percent of teens and young adults.
SPOTLESS features a BPO2 Technology that leverages Benzoyl Peroxide in a groundbreaking new way. Rodan + Fields has developed an innovative liquid form of Benzoyl Peroxide – an industry first – to get through the skin’s stubborn biofilms, helping to bring the microbiome inside the pores back to balance and effectively combat the entire acne cycle. A two-step system, SPOTLESS delivers visible results from Day 1 and makes it easy for teens to be compliant and achieve even better results over time.
”As practicing dermatologists, product developers and women, we understand the emotional, physical and scientific aspects of acne,” said Dr. Katie Rodan, Co-Founder of Rodan + Fields. “Working side-by-side with our team of scientists and innovators we’ve pioneered many skincare firsts, and we’re thrilled to have discovered a game-changing way to treat acne for teens,” said Dr. Kathy Fields, Co-Founder of Rodan + Fields.
Rodan + Fields recognizes the impact acne has on people of all ages – including the 40 percent of adults who experience acne – and knows adult skin requires a different approach than teen skin. With that in mind, the company has updated its UNBLEMISH Regimen, designed to address adult acne, as well as the visible signs of aging, with new formulas that feature Benzoyl Peroxide and Salicylic Acid.
“With our Founders’ unique perspective and expertise, we believe these formulas will be a breakthrough in the category and give the overwhelming majority of consumers who experience acne an easy, at-home solution,” said Diane Dietz, President and CEO of Rodan + Fields. “We are just scratching the surface of the $124B global skincare category and launching SPOTLESS provides a significant opportunity to reach a new set of customers.”
The SPOTLESS and UNBLEMISH Regimens are available through Rodan + Fields Independent Consultants who power the company’s unique consumer-connected commerce model, and at rodanandfields.com.
Source: Rodan + Fields